MCD — Mycodern SA Income Statement
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
Annual income statement for Mycodern SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | PAS | PAS | PAS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.78 | 10.2 | 0.713 | 0.862 | 2.12 |
Cost of Revenue | |||||
Gross Profit | 1.12 | 0.937 | 0.238 | 0.623 | 0.245 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.03 | 15.2 | 1.55 | 0.802 | 2.05 |
Operating Profit | -0.255 | -5 | -0.835 | 0.06 | 0.073 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.254 | -4.99 | -0.84 | -0.008 | -27.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.283 | -4.98 | -0.809 | -0.008 | -27.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.283 | -4.98 | -0.809 | -0.008 | -27.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.283 | -4.98 | -0.809 | -0.008 | -27.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.032 | -0.562 | -0.057 | -0 | -0.884 |